drugset / Trial / NCT04008901

The Efficacy and Safety of "BST104" (Lonicera Flos Extract) in Mild to Moderate Functional Dyspepsia Subjects

NCT04008901 ↗

Phase 3 Completed 92 enrolled Seoul National University Bundang Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study was conducted to prove the efficacy of BST-104 in patients with mild to moderate FD.

Timeline

Start
2017-02-13
Primary completion
2018-07-02
Completion
2018-11-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator BST104 Unknown 175 mg —